Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Vivan Hellström

10PUBLICATIONS
39CO-AUTHORS
Molecular targetsMedical devicesMedia industry studiesPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

Sort by Publication Date:
|Apr 29, 2026
Tumor microenvironment gene engineering with LOAd703 in patients with solid malignancies: LOKON002 phase I/IIb clinical trial.

|Feb 16, 2026
LOAd703-induced tumor microenvironment gene engineering in combination with atezolizumab in metastatic malignant melanoma: a phase I/II trial.

O Hamid, V Ekström-Rydén, I Mehmi

|Dec 12, 2025
Characteristics and overall survival in patients with T1 melanoma: A nationwide matched cohort study.

Ylva Naeser, Rasmus Mikiver, Karolin Isaksson

|Oct 03, 2025
Baseline laboratory values and metastatic burden predict survival in addition to IMDC risk in real-world renal cell carcinoma patients treated with ipilimumab-nivolumab.

Alaa Kheir, Berglind Johannsdottir, Alexandra Grönn-Weiss

|Jan 23, 2025
First-in-human, multicenter, open-label, phase I study of ATOR-1017 (evunzekibart), a 4-1BB antibody, in patients with advanced solid malignancies.

Ana Carneiro, Amanda Hahn, Peter Ellmark

|Jun 28, 2023
Chemokine Analysis in Patients with Metastatic Uveal Melanoma Suggests a Role for CCL21 Signaling in Combined Epigenetic Therapy and Checkpoint Immunotherapy.

Vasu R Sah, Henrik Jespersen, Joakim Karlsson

Pageof 2

Frequent Collaborators

3 joint publications

Angelica Loskog

2 joint publications

Salem Alsaqal

2 joint publications

Sandra Irenaeus

2 joint publications

Tanja Lövgren

2 joint publications

Jessica Wenthe

1 joint publications

O Hamid

1 joint publications

V Ekström-Rydén

1 joint publications

I Mehmi

1 joint publications

D Wang

1 joint publications

M Patel

Frequent Collaborators

3 joint publications

Angelica Loskog

2 joint publications

Salem Alsaqal

2 joint publications

Sandra Irenaeus

2 joint publications

Tanja Lövgren

Top Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on : Jul 25, 2020

6.5K
A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on : May 18, 2018

16.6K
See more related videos

Top Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on : Jul 25, 2020

6.5K
A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on : May 18, 2018

16.6K
See more related videos